Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits
- PMID: 14991906
- DOI: 10.1002/bdrb.10054
Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits
Abstract
Background: The present work was performed to determine the effect of thalidomide exposure on reproductive function and early embryonic development.
Methods: Twenty-five female New Zealand White rabbits were orally gavaged with 0, 10, 50, or 100 mg/kg/day thalidomide 14 days prior to mating through to gestation day 7 for a total of 22 days. Treated females were Caesarean-sectioned approximately 29 days after the date of attempted mating. Following mating with treated females, male rabbits (25/dose) were gavaged with 0, 30, 150, or 500 mg/kg/day beginning 14 days prior to mating with a group of untreated females (25/dose). Doses were administered through mating until the day before sacrifice for a minimum of 56 days. Untreated females were Caesarean-sectioned 29 days after the last attempted mating. Comprehensive necropsy and histopathology of the reproductive system were performed.
Results: Treated females had reduction in body weight gain during gestation. Mating and pregnancy parameters were unaffected by thalidomide. At 100 m/kg, litter averages for corpora lutea, implantations, litter sizes, does with viable fetuses and live fetuses decreased and the number of early resorptions, does with any resorptions, does with all conceptuses resorbed, and the percent resorbed conceptuses per litter increased. The number of early resorptions, the average number of early resorptions per litter, and the percent resorbed conceptuses per litter increased at 10 and 50 mg/kg. There were no thalidomide-related external fetal malformations. Mating and fertility in male rabbits were unaffected by thalidomide. There was an increased incidence of flaccid testes at 150 and 500 mg/kg and of bilateral small testes in all treated groups. At 500 mg/kg, there was degeneration of the germinal epithelium of the testicles with an increase in multinucleated giant cells in seminiferous tubule and a loss of round and elongating spermatids.
Conclusions: Thalidomide had no adverse effects on mating and fertility in male and female rabbits dosed up to 500 and 100 mg/kg/day, respectively, for 14 days prior to mating. After 56 day of dosing, histopathologic changes with no associated sperm abnormalities were observed in the testicles. Embryonic development NOAEL for treated females mated to untreated males was <10 mg/kg. Corresponding fertility NOAEL for treated males mated to untreated females was 500 mg/kg.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Effects of thalidomide on developmental, peri- and postnatal function in female New Zealand white rabbits and offspring.Toxicol Sci. 2004 Oct;81(2):379-89. doi: 10.1093/toxsci/kfh207. Epub 2004 Jun 30. Toxicol Sci. 2004. PMID: 15229368
-
Dietary administration of colesevelam hydrochloride does not affect fertility or reproductive performance in rats.Int J Toxicol. 2004 Nov-Dec;23(6):357-67. doi: 10.1080/10915810490902010. Int J Toxicol. 2004. PMID: 15764491
-
Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.Regul Toxicol Pharmacol. 2006 Aug;45(3):273-81. doi: 10.1016/j.yrtph.2006.05.004. Epub 2006 Jun 30. Regul Toxicol Pharmacol. 2006. PMID: 16814440
-
NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3′-Azido-3′-deoxythymidine (AZT) and Clarithromycin Combinations (CAS Nos. 30516-87-1 and 81103-11-9) Administered by Gavage to Swiss CD-1® Mice [Internet].Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2003 Oct. Report No.: 04-4418. Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2003 Oct. Report No.: 04-4418. PMID: 32479037 Free Books & Documents. Review.
-
Reproduction in female South American domestic camelids.J Reprod Fertil Suppl. 1999;54:169-78. J Reprod Fertil Suppl. 1999. PMID: 10692853 Review.
Cited by
-
FDA-approved medications that impair human spermatogenesis.Oncotarget. 2017 Feb 7;8(6):10714-10725. doi: 10.18632/oncotarget.12956. Oncotarget. 2017. PMID: 27801671 Free PMC article. Review.
-
Convenient screening of the reproductive toxicity of favipiravir and antiviral drugs in Caenorhabditis elegans.Heliyon. 2024 Jul 26;10(15):e35331. doi: 10.1016/j.heliyon.2024.e35331. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39165990 Free PMC article.
-
Behçet's syndrome in pregnancy.Obstet Med. 2010 Mar;3(1):2-7. doi: 10.1258/om.2009.090033. Epub 2010 Mar 4. Obstet Med. 2010. PMID: 27582833 Free PMC article. Review.
-
Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.Arthritis Res Ther. 2006;8(4):215. doi: 10.1186/ar1977. Arthritis Res Ther. 2006. PMID: 16774693 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources